Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33RD Annual Meeting

Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced that the company, along with one of their collaborators, Dr. Sekwon Jang of the Inova Cancer Center, will present new data at the upcoming Society for Immunotherapy of Cancers (SITC) 33rd Annual Meeting, taking place in Washington, D.C., November 9-11, 2018.

Following is a list of abstracts that will be presented at the meeting.

 

Rapid Oral Abstract Presentation Session

Session     Title & Presenter    

Day & Time

 Stay Updated To Save Money & Time. Join Our Free Newsletter 
. Indepth Analysis & Opinion       . Interviews      . Exclusive Reports  
. Free Digital Magazines      News & updates      . Event Invitations 
                     
& Much More Delivered To Your Inbox For Free.
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

 
    Location
Rapid Oral Abstracts    

Molecular profiling of anti-PD-1 treated melanoma patients reveals importance of assessing neoantigen burden and tumor escape mechanisms for clinical treatment Presenter: Sekwon Jang, MD Director, Melanoma and Cutaneous Oncology Therapeutics and Research Inova Melanoma and Skin Cancer Center

   

November 9: 1:40 pm

    204ABC
 

Scientific Poster Presentations

Poster Number & Session     Title & Presenter     Day & Time     Location

P13 Biomarkers and Immune Monitoring

   

Molecular profiling of anti-PD-1 treated melanoma patients reveals importance of assessing neoantigen burden and tumor escape mechanisms for clinical treatment Presenter: Charles W. Abbott, PhD

   

November 9: 12:45pm-2:15pm and 6:30pm-8:00pm

    Hall E

P151 Cancer Vaccines, Personalized Vaccines and Technologies, Personalized Medicine

   

Improving neoantigen identification for therapeutic and diagnostic use in immuno-oncology using mass spectrometry and machine learning Presenter: Sean M. Boyle, PhD

   

November 9: 12:45pm-2:15pm and 6:30pm-8:00pm

    Hall E

P78 Biomarkers and Immune Monitoring

   

More sensitive identification of T-cell receptor beta rearrangements with an augmented transcriptome method Presenter: Eric Levy, PhD

   

November 10: 12:20pm-1:50pm and 7:00pm-8:30pm

    Hall E
           

Personalis will also be exhibiting during the conference (Booth #617). Representatives will be available to answer questions about the companys cancer immunogenomics services.

About Personalis, Inc.

Personalis, Inc. is a leading precision medicine company focused on advanced NGS-based services for immuno-oncology and cancer for clinical trials and translational research. The Personalis ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile and each tumors unique immune microenvironment for immuno-oncology applications. The companys Clinical Laboratory is GxP aligned as well as CLIA88 and CAP accredited. Personalis is differentiated by advanced sequencing assays, algorithms and content for neoantigen characterization, customer regulatory support, and more. Visit our website at www.personalis.com and follow @PersonalisInc.

for Personalis:
Jennifer Havlek, 650-752-1300
[email protected]
www.personalis.com

 Stay Updated To Save Money & Time. Join Our Free Newsletter 
. Indepth Analysis & Opinion       . Interviews      . Exclusive Reports  
. Free Digital Magazines      News & updates      . Event Invitations 
                     
& Much More Delivered To Your Inbox For Free.
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

 
Close
Stay Updated To Save Money & Time. Join Our Free Newsletter. 
. Indepth Analysis & Opinion       Interviews          . Exclusive Reports 
. Free Digital Magazines        . News & updates        . Event Invitations
& Much More Delivered To Your Inbox For Free. 
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.
 
Close